Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yizeng He

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Statistics in Medicine|September 18, 2022
Marginal semiparametric transformation models for clustered multivariate competing risks dataYizeng He, Soyoung Kim, Lu Mao, et al.
Computational Statistics & Data Analysis|May 17, 2021
Optimal treatment regimes for competing risk data using doubly robust outcome weighted learning with bi-level variable selectionYizeng He, Soyoung Kim, Mi-Ok Kim, et al.
Blood|October 29, 2020
Is autologous transplant in relapsed DLBCL patients achieving only a PET+ PR appropriate in the CAR T-cell era?Nirav N Shah, Kwang W Ahn, Carlos Litovich, et al.
WMJ : Official Publication of the State Medical Society of Wisconsin|October 28, 2021
Student Leadership Development Initiative: Benefits of a Unique Medical Student OrganizationAllison R Linehan, Alexander R Chartier, Yizeng He, et al.
Journal of Medical Education and Curricular Development|September 11, 2023
Student Leadership Development Initiative for Medical Students: Lessons Learned From Transitioning to Virtual ModalitiesGopika SenthilKumar, Kelli C Sommers, Yizeng He, et al.
Cephalalgia : an International Journal of Headache|September 26, 2025
Atogepant for the preventive treatment of episodic migraine in Japanese participants: A phase 2/3, randomized, double-blind, placebo-controlled trial with an active treatment extension (RELEASE)Yasuhiko Matsumori, Hiroshi Yamada, Yoshishige Nagaseki, et al.
Headache|November 21, 2024
Safety and tolerability of ubrogepant for the acute treatment of migraine in participants taking atogepant for the preventive treatment of episodic migraine: Results from the TANDEM studyJessica Ailani, Richard B Lipton, Andrew M Blumenfeld, et al.
Cephalalgia : an International Journal of Headache|August 20, 2025
Long-term safety, efficacy and functional outcomes of atogepant for the preventive treatment of migraineSait Ashina, Messoud Ashina, Dagny Holle-Lee, et al.
Haematologica|June 20, 2020
Comparison of total body irradiation <i>versus</i> non-total body irradiation containing regimens for de novo acute myeloid leukemia in childrenChristopher E Dandoy, Stella M Davies, Kwang Woo Ahn, et al.
Cancer|February 13, 2020
Outcomes of rituximab-BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantationDeepa Jagadeesh, Navneet S Majhail, Yizeng He, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Statistics in Medicine|September 18, 2022
Marginal semiparametric transformation models for clustered multivariate competing risks dataYizeng He, Soyoung Kim, Lu Mao, et al.
Computational Statistics & Data Analysis|May 17, 2021
Optimal treatment regimes for competing risk data using doubly robust outcome weighted learning with bi-level variable selectionYizeng He, Soyoung Kim, Mi-Ok Kim, et al.
Blood|October 29, 2020
Is autologous transplant in relapsed DLBCL patients achieving only a PET+ PR appropriate in the CAR T-cell era?Nirav N Shah, Kwang W Ahn, Carlos Litovich, et al.
WMJ : Official Publication of the State Medical Society of Wisconsin|October 28, 2021
Student Leadership Development Initiative: Benefits of a Unique Medical Student OrganizationAllison R Linehan, Alexander R Chartier, Yizeng He, et al.
Journal of Medical Education and Curricular Development|September 11, 2023
Student Leadership Development Initiative for Medical Students: Lessons Learned From Transitioning to Virtual ModalitiesGopika SenthilKumar, Kelli C Sommers, Yizeng He, et al.
Cephalalgia : an International Journal of Headache|September 26, 2025
Atogepant for the preventive treatment of episodic migraine in Japanese participants: A phase 2/3, randomized, double-blind, placebo-controlled trial with an active treatment extension (RELEASE)Yasuhiko Matsumori, Hiroshi Yamada, Yoshishige Nagaseki, et al.
Headache|November 21, 2024
Safety and tolerability of ubrogepant for the acute treatment of migraine in participants taking atogepant for the preventive treatment of episodic migraine: Results from the TANDEM studyJessica Ailani, Richard B Lipton, Andrew M Blumenfeld, et al.
Cephalalgia : an International Journal of Headache|August 20, 2025
Long-term safety, efficacy and functional outcomes of atogepant for the preventive treatment of migraineSait Ashina, Messoud Ashina, Dagny Holle-Lee, et al.
Haematologica|June 20, 2020
Comparison of total body irradiation <i>versus</i> non-total body irradiation containing regimens for de novo acute myeloid leukemia in childrenChristopher E Dandoy, Stella M Davies, Kwang Woo Ahn, et al.
Cancer|February 13, 2020
Outcomes of rituximab-BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantationDeepa Jagadeesh, Navneet S Majhail, Yizeng He, et al.
Pageof 1